Recursion Pharmaceuticals, Inc. (RXRX) Earnings
NASDAQ·Healthcare·Biotechnology
$3.50
-0.14%
Mkt Cap $2.41B
EPS — Estimate vs Actual
Mkt Cap
$2.41B
P/E
—
Fwd P/E
—
P/S
36.29
Rev TTM
—
EPS TTM
-$1.20
NASDAQ·Healthcare·Biotechnology
$3.50
-0.14%
Mkt Cap $2.41B
Mkt Cap
$2.41B
P/E
—
Fwd P/E
—
P/S
36.29
Rev TTM
—
EPS TTM
-$1.20